4//SEC Filing
TILTON GLENN F 4
Accession 0001415889-23-007107
CIK 0001551152other
Filed
May 1, 8:00 PM ET
Accepted
May 2, 5:17 PM ET
Size
5.8 KB
Accession
0001415889-23-007107
Insider Transaction Report
Form 4
AbbVie Inc.ABBV
TILTON GLENN F
Director
Transactions
- Exercise/Conversion
Stock Equivalent Units
2023-04-28$151.12/sh−2,230$336,998→ 34,700 totalExercise: $151.12→ Common Stock (2,230 underlying)
Footnotes (2)
- [F1]The cash equivalent of 2,230 AbbVie stock equivalent units in the Abbott account was paid to the director upon his retirement from Abbott's board on April 28, 2023.
- [F2]Director fees credited to stock equivalent unit accounts under grantor trusts established by the director at Abbott Laboratories and AbbVie. The stock equivalent units in the AbbVie account will be paid, in cash, generally at age 65 or upon retirement from AbbVie's board. The stock equivalent units earn the same return as if the fees were invested in AbbVie stock. Balance includes stock equivalent units acquired pursuant to a dividend reinvestment feature.
Documents
Issuer
AbbVie Inc.
CIK 0001551152
Entity typeother
Related Parties
1- filerCIK 0001194624
Filing Metadata
- Form type
- 4
- Filed
- May 1, 8:00 PM ET
- Accepted
- May 2, 5:17 PM ET
- Size
- 5.8 KB